Healthcare Finance News August 10, 2020
Jeff Lagasse

Pharma companies are also offering solutions to practices so they can more easily afford and keep track of therapies.

As a result of the COVID-19 pandemic, pharmaceutical companies are changing how they engage with healthcare providers, which in turn is helping providers better serve patients, according to findings of a global Accenture survey of 720 general practitioners, oncologists, cardiologists and immunologists.

For example, most providers said pharma companies are increasingly providing education on how to better treat patients remotely and help them manage their conditions in light of COVID-19.

Pharma companies are also helping patients understand where they can access labs, infusion centers or imaging centers, and are offering solutions to providers and their practices so they can more...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Patient / Consumer, Pharma, Pharma / Biotech, Physician, Provider, Survey / Study, Trends
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
AstraZeneca plans independent drug supply chains for US and China, CEO says
Digital Platforms Streamline Medication Access and Delivery
Pharma Pulse 3/27/24: Patients Hate ‘Forever’ Drugs—Is Wegovy Different? Low Melatonin Can Increase Risk of Neurological Disorders & more
Brainomix AI shows its worth in AZ pulmonary fibrosis trial

Share This Article